Jeff L. Vacirca
Director, Odonate Therapeutics, Inc.
Companies
- Caris Life Sciences (United States)Board member Jun 17, 2025 to now1
- Assertio Holdings, Inc.Board member Aug 2, 2023 to Jun 12, 20242
- Spectrum PharmaceuticalsBoard member Nov 14, 2018 to Aug 1, 20233
- Odonate Therapeutics, Inc.Board member Dec 6, 2017 to Jun 28, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Caris Life Sciences (United States) CAI62,863 shares5$1.9M at $30.90Aug 14, 2026
Spectrum Pharmaceuticals SPPI0 shares6Jul 31, 2023- Assertio Holdings, Inc.151,159 shares7Jun 11, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 14, 2026Granted 13,192 shares of Caris Life Sciences (United States)5
- May 11, 2026Bought 31,050 shares at $16.15 of Caris Life Sciences (United States)8
- Feb 26, 2026Granted 2,492 shares at $20.06 of Caris Life Sciences (United States)9
- Jun 11, 2024Bought 10,000 shares at $1.11 of Assertio Holdings, Inc.7
- May 23, 2024Granted 53,750 shares of Assertio Holdings, Inc.10
- Jul 31, 2023Granted 34,767 shares of Assertio Holdings, Inc.11
- Jul 31, 2023Returned to company 295,244 shares of Spectrum Pharmaceuticals6
- Jul 31, 2023Granted 52,642 shares of Assertio Holdings, Inc.11
- Nov 30, 2022Bought 50,000 shares at $0.45 of Spectrum Pharmaceuticals12
- Oct 27, 2022Granted 50,000 shares at $0.43 of Spectrum Pharmaceuticals13
- Aug 31, 2022Granted 25,000 shares of Spectrum Pharmaceuticals14
- Feb 14, 2022Granted 10,000 shares at $0.68 of Spectrum Pharmaceuticals15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed May 12, 2026
- 9SEC EDGARForm 4 filed Feb 27, 2026
- 10SEC EDGARForm 4 filed May 28, 2024
- 11SEC EDGARForm 4 filed Aug 2, 2023
- 12SEC EDGARForm 4 filed Dec 2, 2022
- 13SEC EDGARForm 4 filed Oct 27, 2022
- 14SEC EDGARForm 4 filed Sep 2, 2022
- 15SEC EDGARForm 4 filed Feb 14, 2022